GPT Healthcare Limited (BOM:544131)

GPT Healthcare Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	422.21	499.22	477.69	390.08	416.63
Depreciation & Amortization	265.07	184.58	176.68	147.84	135.31
Other Amortization	5.81	5.72	3.14	1.28	0.59
Loss (Gain) From Sale of Assets	12.68	-3.35	-1.83	-4.51	0.01
Asset Writedown & Restructuring Costs	-	-	2.85	-	-
Loss (Gain) From Sale of Investments	-4.87	-4.01	-2.9	-1.79	-1.93
Provision & Write-off of Bad Debts	26.29	39.67	18.19	4.85	1.96
Other Operating Activities	29.41	-11.78	75.87	105.51	52.78
Change in Accounts Receivable	-35.08	-1.44	-46.05	-77.36	36.42
Change in Inventory	-17.76	-6.7	7.66	-16.36	-8.59
Change in Accounts Payable	72.49	-23.83	45.17	52.27	32.89
Change in Other Net Operating Assets	35.36	-4.11	-68.48	61.75	-6.15
Operating Cash Flow	811.61	673.96	688	663.56	659.92
Operating Cash Flow Growth	20.42%	-2.04%	3.68%	0.55%	50.23%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-418.19	-499.26	-193.67	-98.31	-72.96
Sale of Property, Plant & Equipment	9.71	4.89	1.51	14.61	1.79
Investment in Securities	-82.78	7.37	-219.23	-28.72	-94.86
Other Investing Activities	28.73	49.79	39.12	10.45	11.18
Investing Cash Flow	-472.52	-325.92	-252.06	51.53	-53.39

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	-	2.17	1.5	-	14.03
Long-Term Debt Issued	139.63	93.97	-	2.45	-
Total Debt Issued	139.63	96.14	1.5	2.45	14.03
Short-Term Debt Repaid	-24.55	-	-	-13.52	-
Long-Term Debt Repaid	-204.02	-141.46	-570.65	-322.53	-303.09
Total Debt Repaid	-228.57	-141.46	-570.65	-336.05	-303.09
Net Debt Issued (Repaid)	-88.94	-45.33	-569.15	-333.6	-289.06
Issuance of Common Stock	-	-	400	-	-
Preferred Dividends Paid	-	-	-	-	-47
Common Dividends Paid	-205.14	-287.19	-239.71	-319.62	-125.59
Dividends Paid	-205.14	-287.19	-239.71	-319.62	-172.59
Other Financing Activities	-20.27	-15.87	-76.14	-78.56	-109.96
Financing Cash Flow	-314.34	-348.39	-485.01	-731.78	-571.61

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash Flow	24.74	-0.34	-49.06	-16.69	34.92

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	393.42	174.71	494.33	565.24	586.96
Free Cash Flow Growth	125.19%	-64.66%	-12.55%	-3.70%	58.87%
Free Cash Flow Margin	8.33%	4.29%	12.35%	15.66%	17.40%
Free Cash Flow Per Share	4.79	2.13	6.17	7.07	7.35
Levered Free Cash Flow	206.69	224.84	517.21	559.51	528.32
Unlevered Free Cash Flow	253.84	240.65	557.8	612.28	592.03

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	20.27	15.87	51.35	78.56	109.96
Cash Income Tax Paid	130.28	170.81	150.2	102.9	134.92
Change in Working Capital	55.01	-36.09	-61.69	20.29	54.57

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error